Quarterly report [Sections 13 or 15(d)]

Consolidated Condensed Statements of Cash Flows

v3.25.3
Consolidated Condensed Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 27, 2025
Sep. 28, 2024
Statement of Cash Flows [Abstract]    
Cash and cash equivalents, beginning of period $ 8,249 $ 7,079
Cash flows provided by (used for) operating activities:    
Net income (loss) 359 (19,080)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation 7,971 7,651
Share-based compensation 1,896 2,759
Restructuring and other charges 372 3,626
Amortization of intangibles 708 1,081
(Gains) losses on equity investments, net (611) 75
Mark-to-market (gains) losses on obligation to issue Escrowed Shares 1,687 0
(Gains) losses on divestitures (5,355) 0
Deferred taxes 123 6,368
Impairments and net (gain) loss on retirement of property, plant, and equipment 465 2,290
Changes in assets and liabilities:    
Accounts receivable 162 282
Inventories (9) (969)
Accounts payable (281) 566
Accrued compensation and benefits 541 1,384
Income taxes (1,196) (930)
Other assets and liabilities (1,423) 20
Total adjustments 5,050 24,203
Net cash provided by operating activities 5,409 5,123
Cash flows provided by (used for) investing activities:    
Additions to property, plant and equipment (11,158) (18,110)
Proceeds from capital-related government incentives 1,018 725
Purchases of short-term investments (16,401) (31,519)
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 10,964 34,268
Sales of equity investments 642 503
Proceeds from divestiture 6,186 0
Other investing 494 (359)
Net cash used for investing activities (8,255) (14,492)
Cash flows provided by (used for) financing activities:    
Issuance of commercial paper, net of issuance costs 3,493 7,349
Repayment of commercial paper (3,493) (7,349)
Partner contributions 3,652 12,278
Net proceeds from sales of subsidiary shares 922 0
Additions to property, plant, and equipment (2,493) (741)
Issuance of long-term debt, net of issuance costs 0 2,975
Repayment of debt (3,750) (2,288)
Proceeds from sales of common stock through employee equity incentive plans 777 986
Net proceeds attributed to common stock and warrants issued 3,737 0
Net proceeds attributed to obligation to issue Escrowed Shares 3,945 0
Payment of dividends to stockholders 0 (1,599)
Other financing (1,052) (536)
Net cash provided by (used for) financing activities 5,738 11,075
Net increase (decrease) in cash and cash equivalents 2,892 1,706
Cash and cash equivalents, end of period 11,141 8,785
Non-cash supplemental disclosures:    
Acquisition of property, plant, and equipment1 5,068 [1] 6,595
Recognition of capital-related government incentives 6,094 2,211
Interest, net of capitalized interest 1,156 1,099
Income taxes, net of refunds $ 1,939 $ 1,880
[1] Includes $1,301 million with extended payment terms of greater than 90 days in the nine months ended September 27, 2025.